Utah Medical launches $75-per-share self-tender offer
Utah Medical Products ($UTMD) commenced a tender offer to repurchase up to 650,000 common shares at $75 each. At full acceptance, the share purchase would total $48.75 million before related costs. The offer follows previously announced terms and gives shareholders a defined mechanism to tender stock rather than relying on an open-market repurchase program. The scheduled expiration is October 7 at 5 p.m. New York time, unless extended. A subsequent clarification corrected the weekday to Wednesda
0